Korsana Biosciences, Inc. KRSA
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.28M | 44.00K | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.76M | 143.00K | |||
| Operating Income | -14.76M | -143.00K | |||
| Income Before Tax | -13.51M | -73.00K | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.51M | -73.00K | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.51M | -73.00K | |||
| EBIT | -14.76M | -143.00K | |||
| EBITDA | -- | -- | |||
| EPS Basic | -2.70 | -0.04 | |||
| Normalized Basic EPS | -1.69 | -0.02 | |||
| EPS Diluted | -2.70 | -0.04 | |||
| Normalized Diluted EPS | -1.69 | -0.02 | |||
| Average Basic Shares Outstanding | 5.00M | 2.00M | |||
| Average Diluted Shares Outstanding | 5.00M | 2.00M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||